ES2880754T3 - Métodos mejorados para la acilación de maitansinol - Google Patents

Métodos mejorados para la acilación de maitansinol Download PDF

Info

Publication number
ES2880754T3
ES2880754T3 ES18213678T ES18213678T ES2880754T3 ES 2880754 T3 ES2880754 T3 ES 2880754T3 ES 18213678 T ES18213678 T ES 18213678T ES 18213678 T ES18213678 T ES 18213678T ES 2880754 T3 ES2880754 T3 ES 2880754T3
Authority
ES
Spain
Prior art keywords
formula
group
carboxyanhydride
maytansinol
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18213678T
Other languages
English (en)
Spanish (es)
Inventor
Wayne C Widdison
Robert Yongxin Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunogen Inc
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Application granted granted Critical
Publication of ES2880754T3 publication Critical patent/ES2880754T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R12/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, specially adapted for printed circuits, e.g. printed circuit boards [PCB], flat or ribbon cables, or like generally planar structures, e.g. terminal strips, terminal blocks; Coupling devices specially adapted for printed circuits, flat or ribbon cables, or like generally planar structures; Terminals specially adapted for contact with, or insertion into, printed circuits, flat or ribbon cables, or like generally planar structures
    • H01R12/50—Fixed connections
    • H01R12/51—Fixed connections for rigid printed circuits or like structures
    • H01R12/55—Fixed connections for rigid printed circuits or like structures characterised by the terminals
    • H01R12/58—Fixed connections for rigid printed circuits or like structures characterised by the terminals terminals for insertion into holes
    • H01R12/585—Terminals having a press fit or a compliant portion and a shank passing through a hole in the printed circuit board
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/0201—Thermal arrangements, e.g. for cooling, heating or preventing overheating
    • H05K1/0203—Cooling of mounted components
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/11—Printed elements for providing electric connections to or between printed circuits
    • H05K1/115—Via connections; Lands around holes or via connections
    • H05K1/116—Lands, clearance holes or other lay-out details concerning the surrounding of a via
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/18—Printed circuits structurally associated with non-printed electric components
    • H05K1/181—Printed circuits structurally associated with non-printed electric components associated with surface mounted components

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES18213678T 2012-09-26 2013-09-26 Métodos mejorados para la acilación de maitansinol Active ES2880754T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261705731P 2012-09-26 2012-09-26

Publications (1)

Publication Number Publication Date
ES2880754T3 true ES2880754T3 (es) 2021-11-25

Family

ID=49328648

Family Applications (2)

Application Number Title Priority Date Filing Date
ES18213678T Active ES2880754T3 (es) 2012-09-26 2013-09-26 Métodos mejorados para la acilación de maitansinol
ES13774881T Active ES2716561T3 (es) 2012-09-26 2013-09-26 Métodos mejorados para la acilación de maitansinol

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES13774881T Active ES2716561T3 (es) 2012-09-26 2013-09-26 Métodos mejorados para la acilación de maitansinol

Country Status (27)

Country Link
US (9) US9012629B2 (enExample)
EP (3) EP3904358A1 (enExample)
JP (7) JP6517693B2 (enExample)
CN (2) CN104768955B (enExample)
AU (4) AU2013323572B2 (enExample)
BR (2) BR112015006505B1 (enExample)
CA (2) CA2884873C (enExample)
CY (2) CY1121415T1 (enExample)
DK (2) DK3486248T3 (enExample)
ES (2) ES2880754T3 (enExample)
HR (2) HRP20190473T1 (enExample)
HU (2) HUE055443T2 (enExample)
IL (2) IL237899A (enExample)
LT (2) LT3486248T (enExample)
MX (2) MX390615B (enExample)
MY (1) MY169250A (enExample)
NZ (2) NZ739573A (enExample)
PL (2) PL2900676T3 (enExample)
PT (2) PT3486248T (enExample)
RS (2) RS62075B1 (enExample)
RU (2) RU2648992C2 (enExample)
SG (1) SG11201501918UA (enExample)
SI (2) SI3486248T1 (enExample)
SM (2) SMT201900170T1 (enExample)
TR (1) TR201903625T4 (enExample)
WO (1) WO2014052537A1 (enExample)
ZA (1) ZA201501898B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201900170T1 (it) * 2012-09-26 2019-05-10 Immunogen Inc Metodo migliorato per l'acilazione di maytansinolo
CN105585579A (zh) * 2014-10-24 2016-05-18 南京联宁生物制药有限公司 一种化合物及其制备方法以及美登素dm1的制备方法
WO2016149464A1 (en) * 2015-03-17 2016-09-22 Regeneron Pharmaceuticals, Inc. Amino acid acylation reagents and methods of using the same
EP3554544A4 (en) 2016-12-16 2020-07-29 Bluefin Biomedicine, Inc. ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE
EP3956332B1 (en) 2019-04-18 2023-02-22 Indena S.p.A. Diasteroselective process for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof
US12473579B2 (en) 2019-11-29 2025-11-18 Microbiopharm Japan Co., Ltd. Method for enzymatically producing maytansinol
EP4685150A1 (en) 2023-04-28 2026-01-28 Chugai Seiyaku Kabushiki Kaisha Method for producing amide group-containing compound using n-carboxyamino acid anhydride

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151042A (en) 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
JPS6034556B2 (ja) * 1977-03-31 1985-08-09 武田薬品工業株式会社 抗生物質c−15003
US4137230A (en) 1977-11-14 1979-01-30 Takeda Chemical Industries, Ltd. Method for the production of maytansinoids
US4265814A (en) 1978-03-24 1981-05-05 Takeda Chemical Industries Matansinol 3-n-hexadecanoate
JPS5562090A (en) 1978-10-27 1980-05-10 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5566585A (en) 1978-11-14 1980-05-20 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164687A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS55164685A (en) 1979-06-08 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS55164686A (en) 1979-06-11 1980-12-22 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
US4309428A (en) 1979-07-30 1982-01-05 Takeda Chemical Industries, Ltd. Maytansinoids
JPS5622790A (en) * 1979-07-31 1981-03-03 Takeda Chem Ind Ltd Novel maytansinoid compound and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JP3054741B2 (ja) * 1989-09-29 2000-06-19 武田薬品工業株式会社 Tan―1313およびそのアシル誘導体
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
JP4776843B2 (ja) * 1999-10-01 2011-09-21 イムノゲン インコーポレーティッド 免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
TWI298067B (en) * 2002-01-31 2008-06-21 Daiso Co Ltd New optically active compound, method for kinetic resolution of carbonic acid derivatives and catalyst thereof
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
EP1651162B1 (en) * 2003-05-20 2015-10-21 ImmunoGen, Inc. Improved cytotoxic agents comprising new maytansinoids
MXPA06002088A (es) * 2003-08-22 2006-08-11 Activbiotics Inc Analogos de rifamicina y usos de los mismos.
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
KR101281501B1 (ko) 2004-12-09 2013-07-15 얀센 바이오테크 인코포레이티드 항인테그린 면역 컨쥬게이트, 방법 및 용도
US7301019B2 (en) * 2005-01-21 2007-11-27 Immunogen, Inc. Method for the preparation of maytansinoid esters
WO2007011721A1 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
ATE535529T1 (de) * 2005-08-09 2011-12-15 Millennium Pharm Inc Verfahren zur acylierung von maytansinol mit chiralen aminosäuren
CA2668134A1 (en) * 2006-11-06 2008-05-15 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
JP2008288289A (ja) 2007-05-16 2008-11-27 Oki Electric Ind Co Ltd 電界効果トランジスタとその製造方法
JP5784592B2 (ja) 2009-06-03 2015-09-24 イミュノジェン・インコーポレーテッド 抱合方法
US8754207B2 (en) * 2009-09-25 2014-06-17 Cadila Healthcare Limited Process for the preparation of rapamycin derivatives
EP2640727B1 (en) * 2010-11-17 2015-05-13 Genentech, Inc. Alaninyl maytansinol antibody conjugates
SMT201900170T1 (it) 2012-09-26 2019-05-10 Immunogen Inc Metodo migliorato per l'acilazione di maytansinolo

Also Published As

Publication number Publication date
US9469655B2 (en) 2016-10-18
RS62075B1 (sr) 2021-07-30
DK3486248T3 (da) 2021-07-12
AU2020203823B2 (en) 2021-12-09
JP2022068367A (ja) 2022-05-09
RS58493B1 (sr) 2019-04-30
BR122021022582B1 (pt) 2023-01-10
US20170137440A1 (en) 2017-05-18
EP3904358A1 (en) 2021-11-03
US9796731B2 (en) 2017-10-24
MX366701B (es) 2019-07-22
IL253988A0 (en) 2017-10-31
PL3486248T3 (pl) 2021-10-25
HRP20211030T1 (hr) 2021-10-01
ES2716561T3 (es) 2019-06-13
MX2019008652A (es) 2019-09-13
US10944190B2 (en) 2021-03-09
AU2018201392A1 (en) 2018-03-15
CY1121415T1 (el) 2020-05-29
RU2018109295A3 (enExample) 2021-06-24
JP2020180150A (ja) 2020-11-05
TR201903625T4 (tr) 2019-04-22
EP3486248B1 (en) 2021-04-07
CN104768955B (zh) 2018-04-27
CN108586487A (zh) 2018-09-28
SI2900676T1 (sl) 2019-04-30
AU2013323572B2 (en) 2017-12-07
IL253988B (en) 2019-02-28
HUE055443T2 (hu) 2021-11-29
DK2900676T3 (en) 2019-04-08
ZA201501898B (en) 2019-06-26
JP2024010055A (ja) 2024-01-23
US10100062B2 (en) 2018-10-16
BR112015006505A2 (pt) 2017-07-04
HRP20190473T1 (hr) 2019-05-03
SI3486248T1 (sl) 2021-10-29
LT2900676T (lt) 2019-03-25
EP3486248A1 (en) 2019-05-22
AU2018201392B2 (en) 2020-03-12
AU2013323572A1 (en) 2015-04-02
CA2884873A1 (en) 2014-04-03
US20180099980A1 (en) 2018-04-12
US20250007192A1 (en) 2025-01-02
NZ706019A (en) 2018-03-23
MX2015003745A (es) 2015-06-24
BR112015006505B1 (pt) 2022-03-15
PT3486248T (pt) 2021-07-12
MY169250A (en) 2019-03-19
HUE043285T2 (hu) 2019-08-28
US20240313444A1 (en) 2024-09-19
US9012629B2 (en) 2015-04-21
RU2648992C2 (ru) 2018-03-29
WO2014052537A1 (en) 2014-04-03
HK1212341A1 (en) 2016-06-10
LT3486248T (lt) 2021-08-25
EP2900676A1 (en) 2015-08-05
PT2900676T (pt) 2019-03-29
CN108586487B (zh) 2021-11-05
US20150191488A1 (en) 2015-07-09
JP2018109044A (ja) 2018-07-12
RU2765072C2 (ru) 2022-01-25
CA3133906A1 (en) 2014-04-03
CY1124337T1 (el) 2022-07-22
AU2022201557A1 (en) 2022-03-31
CN104768955A (zh) 2015-07-08
US20140142297A1 (en) 2014-05-22
NZ739573A (en) 2019-11-29
US20190013604A1 (en) 2019-01-10
PL2900676T3 (pl) 2019-06-28
JP2016500657A (ja) 2016-01-14
JP6517693B2 (ja) 2019-05-22
RU2018109295A (ru) 2019-02-26
IL237899A (en) 2017-08-31
JP2020117527A (ja) 2020-08-06
SMT202100390T1 (it) 2021-09-14
US10461449B2 (en) 2019-10-29
AU2020203823A1 (en) 2020-07-02
JP6735000B1 (ja) 2020-08-05
JP2025098242A (ja) 2025-07-01
CA2884873C (en) 2021-11-23
CA3133906C (en) 2023-05-02
US20240145953A1 (en) 2024-05-02
SG11201501918UA (en) 2015-05-28
US20200153130A1 (en) 2020-05-14
RU2015111635A (ru) 2016-11-20
MX390615B (es) 2025-03-20
EP2900676B1 (en) 2018-12-19
SMT201900170T1 (it) 2019-05-10

Similar Documents

Publication Publication Date Title
AU2020203823B2 (en) Improved methods for the acylation of maytansinol
HK40061916A (en) Improved methods for the acylation of maytansinol
HK40008930B (en) Improved methods for the acylation of maytansinol
HK40008930A (en) Improved methods for the acylation of maytansinol
HK1212341B (en) Improved method for the acylation of maytansinol